Ambu stock gains on an IR hire and a sell call
Published on 08/20/2026 at 22:24 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Ambu A/S (DK0060946788) is back in focus after the company named Lisa Bedell Clive as head of investor relations on August 18, 2026, while the stock closed at DKK 75.95 on August 19, 2026 and was down 0.72% on the session.
Shares trade below the year start
The same market snapshot shows a 5-day gain of 2.77% and a year-to-date decline of 13.89%, so the shares are still trading well below where they started 2026. In the same feed, the latest broker item says Danske Bank raised its Ambu target to DKK 61 from DKK 58 and kept a sell view.
Buyback activity stays visible
MarketScreener's Ambu page also listed company announcements from August 17 and August 18 on the share buyback program, which keeps capital allocation in view for investors. The company identity and ticker are matched on that same page, which lists Ambu A/S, DK0060946788 and AMBUBc.
What Ambu sells
Ambu's core business remains single-use endoscopy, anesthesia and patient monitoring, and the August 18 release said the new IR lead brings 25 years of capital markets experience, including two decades at Bernstein covering European medtech. That background matters because Ambu has been trying to sharpen how the market reads its growth story and capital allocation.
Price level to watch
Ambu stock closed at DKK 75.95 on August 19, 2026, with the year-to-date change at minus 13.89% and the 5-day move at plus 2.77%. Those figures frame the current setup better than any generic sector slogan.
More on Ambu stock
Company: Ambu A/S
ISIN: DK0060946788
Ticker: AMBUBc
Exchange: CBOE
Price (as of August 19, 2026, 10:55 a.m. ET): DKK 75.95
Market cap: DKK 20.84 billion
Sector / Industry: Medical Equipment, Supplies & Distribution
Index membership: OMX Copenhagen 25
